{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:17:19Z","timestamp":1792289839422,"version":"4.4.0"},"reference-count":95,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>With the continuing progress in managing patients with thalassemia, especially in the setting of iron overload and iron chelation, the life span of these patients is increasing, while concomitantly increasing incidences of many diseases that were less likely to show when survival was rather limited. Hepatocellular carcinoma (HCC) is a major life-threatening cancer that is becoming more frequently identified in this population of patients. The two established risk factors for the development of HCC in thalassemia include iron overload and viral hepatitis with or without cirrhosis. Increased iron burden is becoming a major HCC risk factor in this patient population, especially in those in the older age group. As such, screening thalassemia patients using liver iron concentration (LIC) measurement by means of magnetic resonance imaging (MRI) and liver ultrasound is strongly recommended for the early detection of iron overload and for implementation of early iron chelation in an attempt to prevent organ-damaging iron overload and possibly HCC. There remain lacking data on HCC treatment outcomes in patients who have thalassemia. However, a personalized approach tailored to each patient\u2019s comorbidities is essential to treatment success. Multicenter studies investigating the long-term outcomes of currently available therapeutic options in the thalassemia realm, in addition to novel HCC therapeutic targets, are needed to further improve the prognosis of these patients.<\/jats:p>","DOI":"10.3390\/ijms19124070","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T02:15:59Z","timestamp":1545099359000},"page":"4070","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hepatocellular Carcinoma in \u03b2-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5635-1895","authenticated-orcid":false,"given":"Antoine","family":"Finianos","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut 11-0236, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-7408","authenticated-orcid":false,"given":"Charbel F.","family":"Matar","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut 11-0236, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Taher","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut 11-0236, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjh.13820","article-title":"Ineffective erythropoiesis and regulation of iron status in iron loading anaemias","volume":"172","author":"Camaschella","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4254\/wjh.v2.i5.171","article-title":"Hepatocellular carcinoma in thalassemia: A critical review","volume":"2","author":"Mancuso","year":"2010","journal-title":"World J. Hepatol."},{"key":"ref_4","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Rugolotto","year":"2004","journal-title":"Haematologica"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.30462","article-title":"Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review","volume":"123","author":"Moukhadder","year":"2017","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s005350170134","article-title":"Different clinicopathological features of hepatocellular carcinoma in relation to causative agents","volume":"36","author":"Shiratori","year":"2001","journal-title":"J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"Mason","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1423-0410.2000.7930129.x","article-title":"Benefits and complications of regular blood transfusion in patients with \u03b2-thalassaemia major","volume":"79","author":"Prati","year":"2000","journal-title":"Vox Sang."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mpo.2950140610","article-title":"Hepatocellular carcinoma in thalassemia major","volume":"14","author":"Sessa","year":"1986","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"334","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0609.2011.01582.x","article-title":"Survival in a large cohort of Greek patients with transfusion-dependent \u03b2 thalassaemia and mortality ratios compared to the general population","volume":"86","author":"Ladis","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjh.13009","article-title":"Hepatocellular carcinoma in thalassaemia: An update of the Italian Registry","volume":"167","author":"Garani","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_16","first-page":"404","article-title":"Incidence of hepatocellular carcinoma in patients with thalassemia who had hepatitis C","volume":"51","author":"Ansari","year":"2013","journal-title":"Acta Med. Iran."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04732.x","article-title":"Hepatocellular carcinoma in the thalassaemia syndromes","volume":"124","author":"Vergine","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/03630269.2010.485071","article-title":"Incidence of hepatocellular carcinoma in a thalassemia unit","volume":"34","author":"Fragatou","year":"2010","journal-title":"Hemoglobin"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1665-2681(19)31397-3","article-title":"Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosis","volume":"12","author":"Maakaron","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Maakaron, J.E., Musallam, K.M., Ayache, J.B., Jabbour, M., Tawil, A.N., and Taher, A.T. (2013). A liver mass in an iron-overloaded thalassaemia intermedia patient. Br. J. Haematol., 161.","DOI":"10.1111\/bjh.12195"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ajh.20289","article-title":"Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic","volume":"78","author":"Mancuso","year":"2005","journal-title":"Am. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03630260500455565","article-title":"A prospective study of hepatocellular carcinoma incidence in thalassemia","volume":"30","author":"Mancuso","year":"2006","journal-title":"Hemoglobin"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/03630269.2018.1434197","article-title":"Hepatocellular Carcinoma in a \u03b2-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic","volume":"42","author":"Moukhadder","year":"2018","journal-title":"Hemoglobin"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2010.08180.x","article-title":"Hepatocellular carcinoma in patients with thalassaemia syndromes: Clinical characteristics and outcome in a long term single centre experience","volume":"150","author":"Renda","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective","volume":"15","author":"Venook","year":"2010","journal-title":"Oncologist"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.3949\/ccjm.76.s3.02","article-title":"Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment","volume":"76","author":"Sherman","year":"2009","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.21037\/jgo.2017.03.14","article-title":"Viral hepatitis and hepatocellular carcinoma: Etiology and management","volume":"8","author":"Zamor","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1158\/0008-5472.CAN-08-0905","article-title":"Hepatitis B virus-associated multistep hepatocarcinogenesis: A stepwise increase in allelic alterations","volume":"68","author":"Lee","year":"2008","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis","volume":"132","author":"Rudolph","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1349-7006.2009.01383.x","article-title":"Genome-wide DNA methylation profiles in precancerous conditions and cancers","volume":"101","author":"Kanai","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2010.08.021","article-title":"Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis","volume":"54","author":"Um","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?","volume":"60","author":"Kanwal","year":"2014","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.gastro.2005.03.089","article-title":"Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells","volume":"129","author":"Preimel","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jcp.43.8.638","article-title":"Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major","volume":"43","author":"Wonke","year":"1990","journal-title":"J. Clin. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00535-012-0641-9","article-title":"Inhibition of hepatocellular carcinoma by PegIFN\u03b1-2a in patients with chronic hepatitis C: A nationwide multicenter cooperative study","volume":"48","author":"Izumi","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-142-2-200501180-00009","article-title":"Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival","volume":"142","author":"Shiratori","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.seminoncol.2012.05.006","article-title":"Causes of and prevention strategies for hepatocellular carcinoma","volume":"39","author":"Cabibbo","year":"2012","journal-title":"Semin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/cncr.20537","article-title":"Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy","volume":"101","author":"Makiyama","year":"2004","journal-title":"Cancer"},{"key":"ref_42","first-page":"508","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy","volume":"49","author":"Hayashi","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00042737-200511000-00020","article-title":"Occurrence of hepatocellular carcinoma in an apparently \u2018healthy\u2019 HCV patient","volume":"17","author":"Puoti","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3851\/IMP1842","article-title":"Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients","volume":"16","author":"Hung","year":"2011","journal-title":"Antivir. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874357901812010016","article-title":"Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals","volume":"12","author":"Schietroma","year":"2018","journal-title":"Open Virol. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, hemochromatosis, and hepatocellular carcinoma","volume":"127","author":"Kowdley","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_47","first-page":"37","article-title":"Hepatocellular carcinoma in hereditary hemochromatosis","volume":"7","author":"Adams","year":"1993","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1258\/096914103321610743","article-title":"Hereditary haemochromatosis and hepatocellular carcinoma in males: A strategy for estimating the potential for primary prevention","volume":"10","author":"Haddow","year":"2003","journal-title":"J. Med. Screen."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.510270614","article-title":"Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans","volume":"27","author":"Mandishona","year":"1998","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0168-8278(00)80250-0","article-title":"Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver","volume":"32","author":"Blanc","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/jhep.2000.9033","article-title":"Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases","volume":"32","author":"Bralet","year":"2000","journal-title":"Hepatology"},{"key":"ref_52","first-page":"446","article-title":"Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver","volume":"22","author":"Turlin","year":"1995","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2010.05585.x","article-title":"Hepcidin in \u03b2-thalassemia","volume":"1202","author":"Nemeth","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2009.07810.x","article-title":"Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia","volume":"146","author":"Taher","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1542-3565(03)00126-5","article-title":"Iron, HFE mutations, and hepatocellular carcinoma: Is hepatic iron a carcinogen?","volume":"1","author":"Ioannou","year":"2003","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0891-5849(95)02111-6","article-title":"Iron-induced carcinogenesis: The role of redox regulation","volume":"20","author":"Toyokuni","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1992.tb08906.x","article-title":"Effect of transferrin, lactoferrin and chelated iron on human T-lymphocytes","volume":"80","author":"Djeha","year":"1992","journal-title":"Br. J. Haematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1440-1746.2001.02430.x","article-title":"Iron and hepatocellular carcinoma","volume":"16","author":"Deugnier","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.1840110407","article-title":"Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines","volume":"11","author":"Hann","year":"1990","journal-title":"Hepatology"},{"key":"ref_60","first-page":"3968","article-title":"Neuroblastoma sensitivity to growth inhibition by deferrioxamine: Evidence for a block in G1 phase of the cell cycle","volume":"53","author":"Brodie","year":"1993","journal-title":"Cancer Res."},{"key":"ref_61","first-page":"47","article-title":"The risk of Hepatocellular carcinoma in patients with thalassemia. A review","volume":"25","author":"Fabbri","year":"2009","journal-title":"Acta Pediatr Mediterr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1073\/pnas.85.11.3918","article-title":"Mutagenesis by the autoxidation of iron with isolated DNA","volume":"85","author":"Loeb","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0891-5849(97)00016-6","article-title":"Iron homeostasis, oxidative stress, and DNA damage","volume":"23","author":"Meneghini","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","article-title":"Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations","volume":"265","author":"Cho","year":"1994","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0016-5085(99)70562-7","article-title":"p53 mutations in british patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis","volume":"117","author":"Vautier","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12770","DOI":"10.1073\/pnas.220416097","article-title":"Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: Oxyradical overload diseases","volume":"97","author":"Hussain","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/93.21.1652","article-title":"Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma","volume":"93","author":"Marrogi","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1440-1622.1999.01656.x","article-title":"Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer","volume":"69","author":"Alagol","year":"1999","journal-title":"Aust. N. Z. J. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"15102","DOI":"10.1073\/pnas.93.26.15102","article-title":"Mutagenesis associated with nitric oxide production in transgenic SJL mice","volume":"93","author":"Gal","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1098-2280(2000)35:1<39::AID-EM6>3.0.CO;2-H","article-title":"Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium","volume":"35","author":"Zhuang","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/carcin\/19.5.711","article-title":"The multifaceted roles of nitric oxide in cancer","volume":"19","author":"Wink","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref_72","first-page":"435","article-title":"Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson\u2019s disease and primary hemochromatosis","volume":"7","author":"Nair","year":"1998","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0022-2143(99)90022-7","article-title":"Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury","volume":"133","author":"Niemela","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1749-6632.1988.tb55514.x","article-title":"Iron inhibits the nonspecific tumoricidal activity of macrophages. A possible contributory mechanism for neoplasia in hemochromatosis","volume":"526","author":"Green","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000163692","article-title":"Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways","volume":"60","author":"Seligman","year":"1992","journal-title":"Pathobiology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"De Sousa, M., Porto, G., Arosa, F.A., Cardoso, C., Cabeda, J.M., LaCerda, R., and Fraga, J. (2000). T-lymphocyte expression and function in hemochromatosis. Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment, Cambridge University Press.","DOI":"10.1017\/CBO9780511666476.039"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0008-8749(87)90293-0","article-title":"Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase","volume":"109","author":"Harada","year":"1987","journal-title":"Cell. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2141.1979.tb01142.x","article-title":"Suppressive effect of ferritin on in vitro lymphocyte function","volume":"42","author":"Matzner","year":"1979","journal-title":"Br. J. Haematol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2009.02.011","article-title":"Liver fibrosis: Screening is not staging","volume":"50","author":"Bedossa","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jcp.35.5.487","article-title":"Effect of ascorbic acid deficiency on serum ferritin concentration in patients with \u03b2-thalassaemia major and iron overload","volume":"35","author":"Chapman","year":"1982","journal-title":"J. Clin. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ejh.12444","article-title":"Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: Serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment","volume":"94","author":"Chirico","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.21275","article-title":"Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients","volume":"49","author":"Pakbaz","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes","volume":"10","author":"Kontoghiorghe","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mric.2010.08.014","article-title":"Magnetic resonance imaging quantification of liver iron","volume":"18","author":"Sirlin","year":"2010","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"ref_87","first-page":"38","article-title":"Surveillance and Diagnosis of Hepatocellular Carcinoma","volume":"11","author":"Fitzmorris","year":"2015","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with \u03b2-thalassemia","volume":"107","author":"Cappellini","year":"2006","journal-title":"Blood"},{"key":"ref_89","unstructured":"Cappellini, M.-D., Cohen, A., Porter, J., Taher, A., and Viprakasit, V. (2014). Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT), Thalassaemia International Federation Nicosia."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3324\/haematol.2012.066845","article-title":"Non-transfusion-dependent thalassemias","volume":"98","author":"Musallam","year":"2013","journal-title":"Haematologica"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03256447","article-title":"New strategies for blood donor screening for hepatitis B virus: Nucleic acid testing versus immunoassay methods","volume":"10","author":"Kuhns","year":"2006","journal-title":"Mol. Diagn. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3748\/wjg.15.3210","article-title":"Current management strategy of hepatocellular carcinoma","volume":"15","author":"Rampone","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13098","article-title":"Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?","volume":"168","author":"Mancuso","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4254\/wjh.v5.i6.302","article-title":"Management of hepatocellular carcinoma: Enlightening the gray zones","volume":"5","author":"Mancuso","year":"2013","journal-title":"World J. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199404213301605","article-title":"Brief report: Combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous \u03b2-thalassemia","volume":"330","author":"Olivieri","year":"1994","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/4070\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:34:23Z","timestamp":1760196863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/4070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":95,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["ijms19124070"],"URL":"https:\/\/doi.org\/10.3390\/ijms19124070","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]}}}